RWJ 67657

Known as: RWJ-67657 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2003
0120012003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
BACKGROUND To evaluate the possibility of preventing endotoxin induced renal damage by p38-MAPK inhibition in a human model… (More)
Is this relevant?
2003
2003
The objective of this study was to investigate the pharmacokinetics and ex vivo pharmacodynamics of increasing doses of RWJ 67657… (More)
Is this relevant?
2002
2002
In the present study, we investigated the effect of RWJ-67657, a p38 MAP kinase inhibitor, upon in vivo LPS-induced monocyte… (More)
Is this relevant?
2002
2002
OBJECTIVE We studied the activity of a single oral dose of RWJ-67657, a synthetic p38 mitogen-activated protein kinase inhibitor… (More)
Is this relevant?
2001
2001
UNLABELLED Sepsis resulting in multiorgan failure and death is still a major problem in intensive care medicine, despite… (More)
Is this relevant?